Scientists for cancer and immuno-oncology biomarker discovery; flow cytometry and mass spectrometry-based proteomics
At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes.
For the 28th year, MSK has been named a top hospital for cancer by U.S. News & World Report. We are proud to be on Becker’s Healthcare list as one of the 150 Great Places to Work in Healthcare in 2018, as well as one of Glassdoor’s Employees’ Choice Best Place to Work for 2018. We’re treating cancer, one patient at a time. Join us and make a difference every day.
The Hematopathology Service is seeking a postdoctoral scientist with experience in multiparameter flow cytometry and flow sorting to lead a clinical flow cytometry based discovery and assay development program for assessment of cellular cancer biomarkers.
The Hematopathology Service is seeking a postdoctoral scientist with experience in multiparameter flow cytometry and flow sorting to lead a clinical flow cytometry based assay development program for assessment of cellular cancer biomarkers.
The ideal candidate is expected to have hands on experience on cutting-edge flow cytometry-based biomarker assays and flow cytometry based cell sorting. He or she will develop, validate and implement flow cytometry immunophenotyping assays to detect diagnostic, prognostic and predictive cancer biomarkers in hematological malignancies. Will be responsible for implementing tumor immune monitoring assays and coordinating large funded translational projects in tumor immunology. Will be responsible for collecting and analyzing multi parameter flow cytometry data with unprecedented opportunities to present prominent national and international meetings and for publications in high impact journals. He or she will also collaborate with the clinical proteomics laboratory within the hematopathology service to develop cell sorting workflows for downstream mass spectrometry-based proteomics analysis. There will be extensive opportunities to interact with physicians and scientists of MSK, and access to outstanding technical, bioinformatic and biospecimen resources of the institute. The position is an ideal stepping stone for future leadership roles in clinical and research laboratories in cancer diagnosis and biology and immunology.
• The candidate is required to have PhD or equivalent degree in biological or medical science.
• Extensive experience in multiparameter flow cytometric immunophenotyping and flow-cytometry-based cell sorting is desirable.
• Evidence of independent and creative research, scientific productivity, and good inter-personal and communication skills.
• Prior hands-on experience in assay development in hematologic cancer and/or immunology strongly preferred.
Interested candidates should submit their CV, letter of interest and references to:
Jessica Wardrope, Manager, Hospital Operations, Pathology
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.